Co-Authors
This is a "connection" page, showing publications co-authored by Loredana Sarmati and Daniela Fraboni.
Connection Strength
0.477
-
T-cell responses to SARS-CoV-2 in multiple sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-spike antibody titers. Mult Scler Relat Disord. 2021 Oct; 55:103157.
Score: 0.239
-
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study. Sci Rep. 2021 06 17; 11(1):12762.
Score: 0.238